L. Ceolin, M.A.D.S. Duval, A.F. Benini, C.V. Ferreira, A.L. Maia, Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives. Endocr. Relat. Cancer. 26(9), R499–R518 (2019). https://doi.org/10.1530/ERC-18-0574

Article  PubMed  CAS  Google Scholar 

S.A. Jr Wells, F. Pacini, B.G. Robinson, M. Santoro, Multiple endocrine neoplasia type 2 and Familial medullary thyroid carcinoma: an update. J. Clin. Endocrinol. Metab. 98(8), 3149–3164 (2013). https://doi.org/10.1210/jc.2013-1204

Article  PubMed  PubMed Central  CAS  Google Scholar 

S.G. Waguespack, T.A. Rich, N.D. Perrier, C. Jimenez, G.J. Cote, Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat. Rev. Endocrinol. 7(10), 596–607 (2011). Published 2011 Aug 23. https://doi.org/10.1038/nrendo.2011.139

Article  PubMed  CAS  Google Scholar 

S.G. Hensley, M.I. Hu, R.L. Bassett, A.K. Ying, M.E. Zafereo, N.D. Perrier, N.L. Busaidy, S.M. Hyde, E.G. Grubbs, S.G. Waguespack, Pediatric medullary thyroid carcinoma: clinical presentations and Long-Term outcomes in 144 patients over 6 decades. J. Clin. Endocrinol. Metab. 109(9), 2256–2268 (2024). https://doi.org/10.1210/clinem/dgae133

Article  PubMed  PubMed Central  CAS  Google Scholar 

S. Richards, N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster, W.W. Grody, M. Hegde, E. Lyon, E. Spector, K. Voelkerding, H.L. Rehm, ACMG Laboratory Quality Assurance Committee, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 17(5), 405–424 (2015). https://doi.org/10.1038/gim.2015.30

Article  PubMed  PubMed Central  Google Scholar 

J.S. Mathiesen, G. Effraimidis, M. Rossing, Å.K. Rasmussen, L. Hoejberg, L. Bastholt, C. Godballe, P. Oturai, U. Feldt-Rasmussen, Multiple endocrine neoplasia type 2: A review. Semin Cancer Biol. 79, 163–179 (2022). https://doi.org/10.1016/j.semcancer.2021.03.035

Article  PubMed  CAS  Google Scholar 

S.A. Jr Wells, S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel, N. Lee, A. Machens, J.F. Moley, F. Pacini, F. Raue, K. Frank-Raue, B. Robinson, M.S. Rosenthal, M. Santoro, M. Schlumberger, M. Shah, S.G. Waguespack, American thyroid association guidelines task force on medullary thyroid carcinoma. Revised American thyroid association guidelines for the management of medullary thyroid carcinoma. Thyroid. 25(6), 567–610 (2015). https://doi.org/10.1089/thy.2014.0335

Article  PubMed  PubMed Central  Google Scholar 

A.L. Maia, D.R. Siqueira, M.A. Kulcsar, A.J. Tincani, G.M. Mazeto, L.M. Maciel, Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the thyroid department of the Brazilian society of endocrinology and metabolism. Arq. Bras. Endocrinol. Metabol. 58(7), 667–700 (2014). English, Portuguese. https://doi.org/10.1590/0004-2730000003427

Article  PubMed  Google Scholar 

R. Elisei, M. Alevizaki, B. Conte-Devolx, K. Frank-Raue, V. Leite, G.R. Williams, 2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer. Eur Thyroid J. 1(4), 216 – 31 (2013). https://doi.org/10.1159/000346174

Article  PubMed  CAS  Google Scholar 

C. Eng, D. Clayton, I. Schuffenecker, G. Lenoir, G. Cote, R.F. Gagel, H.K. van Amstel, C.J. Lips, I. Nishisho, S.I. Takai, D.J. Marsh, B.G. Robinson, K. Frank-Raue, F. Raue, F. Xue, W.W. Noll, C. Romei, F. Pacini, M. Fink, B. Niederle, J. Zedenius, M. Nordenskjöld, P. Komminoth, G.N. Hendy, L.M. Mulligan et al., The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276(19), 1575–1579 (1996)

Article  PubMed  CAS  Google Scholar 

A. Machens, O. Gimm, R. Hinze, W. Höppner, B.O. Boehm, H. Dralle, Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties. J. Clin. Endocrinol. Metab. 86(3), 1104–1109 (2001). https://doi.org/10.1210/jcem.86.3.7290

Article  PubMed  CAS  Google Scholar 

M.K. Puñales, H. Graf, J.L. Gross, A.L. Maia, RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome. J. Clin. Endocrinol. Metab. 88(6), 2644–2649 (2003). https://doi.org/10.1210/jc.2002-021422

Article  PubMed  CAS  Google Scholar 

R.M.B. Maciel, C.P. Camacho, L.V.M. Assumpção, N.E. Bufalo, A.L. Carvalho, de G.A. Carvalho, L.A. Castroneves, de F.M. Castro, L. Ceolin, J.M. Cerutti, R. Corbo, T.M.B.L. Ferraz, C.V. Ferreira, M.I.C. França, H.C.R. Galvão, F. Germano-Neto, H. Graf, A.A.L. Jorge, I.S. Kunii, M.W. Lauria, V.L.G. Leal, S.C. Lindsey, D.M. Lourenço, L.M.Z. Maciel, P.K.R. Magalhães, J.R.M. Martins, M.C. Martins-Costa, G.M.F.S. Mazeto, A.I. Impellizzeri, C.R. Nogueira, E.I. Palmero, C.H.C.N. Pessoa, B. Prada, D.R. Siqueira, M.S.A. Sousa, R.A. Toledo, F.O.F. Valente, F. Vaisman, L.S. Ward, S.S. Weber, R.V. Weiss, J.H. Yang, M.R. Dias-da-Silva, A.O. Hoff, S.P.A. Toledo, A.L. Maia, Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the brasmen study. Endocr. Connect. 8(3), 289–298 (2019). https://doi.org/10.1530/EC-18-0506

Article  PubMed  PubMed Central  CAS  Google Scholar 

K.L. Long, C. Etzel, T. Rich, S. Hyde, N.D. Perrier, P.H. Graham, J.E. Lee, M.I. Hu, G.J. Cote, R. Gagel, E.G. Grubbs, All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients. Fam Cancer. 16(2), 283–289 (2017). https://doi.org/10.1007/s10689-016-9948-7

Article  PubMed  Google Scholar 

S. Roman, R. Lin, J.A. Sosa, Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 107, 2134–2142 (2006). https://doi.org/10.1002/cncr.22244

Article  PubMed  Google Scholar 

Z. Al-Qurayshi, H. Khadra, K. Chang, N. Pagedar, G.W. Randolph, E. Kandil, Risk and survival of patients with medullary thyroid cancer: National perspective. Oral Oncol. 83, 59–63 (2018). https://doi.org/10.1016/j.oraloncology.2018.06.002

Article  PubMed  Google Scholar 

A. Machens, D. Henning, Therapeutic effectiveness of screening for multiple endocrine neoplasia type 2A. J. Clin. Endocrinol. Metab. 100, 2539–2545 (2015). https://doi.org/10.1210/jc.2015-1689

Article  PubMed  CAS  Google Scholar 

W.P. Kluijfhout, van D.J. Beek, A.A. Verrijn Stuart, L. Lodewijk, G.D. Valk, van der D.C. Zee, M.R. Vriens, I.H.M. Borel Rinkes, Postoperative complications after prophylactic thyroidectomy for very young patients with multiple endocrine neoplasia type 2: retrospective cohort analysis. Med. (Baltim). 94(29), e1108 (2015). https://doi.org/10.1097/MD.0000000000001108

Article  Google Scholar 

R. Elisei, C. Romei, G. Renzini, V. Bottici, B. Cosci, E. Molinaro, L. Agate, V. Cappagli, P. Miccoli, P. Berti, P. Faviana, C. Ugolini, F. Basolo, P. Vitti, A. Pinchera, The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. J. Clin. Endocrinol. Metab. 97(2), 426–435 (2012). https://doi.org/10.1210/jc.2011-2046

Article  PubMed  CAS  Google Scholar 

V. Rohmer, G. Vidal-Trecan, A. Bourdelot, P. Niccoli, A. Murat, J.L. Wemeau, F. Borson-Chazot, C. Schvartz, A. Tabarin, O. Chabre, G. Chabrier, P. Caron, P. Rodien, M. Schlumberger, E. Baudin, Groupe Français des tumeurs endocrines. Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the groupe Francais d’etude des tumeurs endocrines. J. Clin. Endocrinol. Metab. 96(3), E509–E518 (2011). https://doi.org/10.1210/jc.2010-1234

Article  PubMed  CAS  Google Scholar 

E.M. Opsahl, M. Brauckhoff, E. Schlichting, K. Helset, J. Svartberg, K. Brauckhoff, L. Mæhle, L.F. Engebretsen, E. Sigstad, K.K. Grøholt, L.A. Akslen, L.H. Jørgensen, J.E. Varhaug, T. Bjøro, A nationwide study of multiple endocrine neoplasia type 2A in norway: predictive and prognostic factors for the clinical course of medullary thyroid carcinoma. Thyroid. 26(9), 1225–1238 (2016). https://doi.org/10.1089/thy.2015.0673

Article  PubMed  CAS  Google Scholar 

A. Machens, U. Schneyer, H.J. Holzhausen, H. Dralle, Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J. Clin. Endocrinol. Metab. 90(4), 2029–2034 (2005). https://doi.org/10.1210/jc.2004-1836

Article  PubMed  CAS  Google Scholar 

A. Prete, A. Matrone, C. Gambale, V. Bottici, V. Cappagli, C. Romei, L. Torregrossa, L. Valerio, E. Minaldi, M.C. Campopiano, L. Lorusso, L. Agate, E. Molinaro, D. Viola, T. Ramone, C. Mulè, R. Ciampi, F. Basolo, R. Elisei, Active surveillance in RET gene carriers belonging to families with multiple endocrine neoplasia. Cancers (Basel). 13(21), 5554 (2021). https://doi.org/10.3390/cancers13215554

Article  PubMed  CAS  Google Scholar 

S.C. Lindsey, I.S. Kunii, F. Germano-Neto, M.Y. Sittoni, C.P. Camacho, F.O. Valente, J.H. Yang, P.S. Signorini, R. Delcelo, J.M. Cerutti, R.M. Maciel, M.R. Dias-da-Silva, Extended RET gene analysis in patients with apparently sporadic medullary thyroid cancer: clinical benefits and cost. Horm. Cancer. 3(4), 181–186 (2012). https://doi.org/10.1007/s12672-012-0109-7

Article  PubMed  PubMed Central  CAS  Google Scholar 

C.P. Camacho, S.C. Lindsey, T.S. Kasamatsu, A.L. Machado, J.R. Martins, R.P. Biscolla, M.R. Dias da Silva, J.G. Vieira, R.M. Maciel, Development and application of a novel sensitive immunometric assay for calcitonin in a large cohort of patients with medullary and differentiated thyroid cancer, thyroid nodules, and autoimmune thyroid diseases. Eur. Thyroid J. 3(2), 117–124 (2014). https://doi.org/10.115